Prevalence of a Localized or Diffuse Pruritus in a Population With One or Several, Primitive or Secondary, Brain Tumor(s)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-29

Study Completion Date

2021-09-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The association between the presence of pruritus, especially centrofacial, and the presence of a brain tumor is a widespread notion in the medical community but based on a single publication by Andreev et al. in the British Journal of Dermatology published in 1975. No other study has studied this association with a rigorous methodology. The aim of this study is to evaluate the prevalence of pruritus in patients with one or more primary or secondary brain tumor(s), benign(s) or malignant(s).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Genetic and Molecular Characterization of Nervous System Lesions

NCT06314607

Brain Tumor Brain Lesion (General)

RECRUITING

Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.

NCT03115138

Glioblastoma Molecular Disease

TERMINATED NA

Components of Social Functioning in Survivors of Pediatric Brain Tumors

NCT03361033

Brain Tumor, Pediatric Medulloblastoma, Pediatric

COMPLETED

Role of the Tumor Microenvironment in Aggressive Meningiomas

NCT05821790

Meningioma

UNKNOWN

A Family Study of Adults With Glioma

NCT00339352

Glioma

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* Monocentric prospective observational study
* On the inclusion period
* Patients who are seen in radiotherapy consultation and / or department of neurosurgery
* Complying with the inclusion criteria, not falling within the exclusion criteria
* Re-reading of cerebral MRI (cMRI) with precision on the location(s) of the brain tumor(s) according to a predefined anatomic descriptive diagram
* Complete the questionnaire by a dermatologist (characteristics of pruritus, brain lesion(s), characteristics of the population)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pruritus Brain Tumor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 18 years
* Diagnosis of benign or malignant brain tumor, primary or secondary.
* Accepted non-opposition
* Realization of a cerebral MRI (cMRI)

Exclusion Criteria

* Age \< 18 years
* Absence of cerebral imaging of the cMRI type
* Absence of non opposition
* Realization of a treatment modifying the brain structure (radiotherapy / surgery)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No